Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details) - Schedule of options outstanding and exercisable

v3.20.2
Stockholders’ Equity (Details) - Schedule of options outstanding and exercisable
 9 Months Ended
Sep. 30, 2020
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Outstanding Number of Options 2,430,000
Exercisable Number of Options 100,000
2.11 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares $ 2.11
Outstanding Number of Options 80,000
Weighted Average Remaining Life In Years
Exercisable Number of Options
2.17 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares $ 2.17
Outstanding Number of Options 120,000
Weighted Average Remaining Life In Years
Exercisable Number of Options
4.09 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares $ 4.09
Outstanding Number of Options 1,890,000
Weighted Average Remaining Life In Years
Exercisable Number of Options
5.66 [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price (in Dollars per share) | $ / shares $ 5.66
Outstanding Number of Options 340,000
Weighted Average Remaining Life In Years 2 years 4 months 17 days
Exercisable Number of Options 100,000